Maintain Medicare's Six Protected Classes status for depression and schizophrenia H.R. 4299, Improving Regulatory Transparency for New Medical Therapies Act
DEA regulatory transparency in controlled substances scheduling process
DEA regulatory transparency in issuing research licenses and quotas Advance the use of FDA-approved medicines to treat addiction in criminal justice settings
H.R.3465/S.1690, The Second Chance Act of 2013 - the use of FDA-approved medicines in criminal justice settings
S.1675, Recidivism Reduction and Public Safety Act of 2013 - the use of FDA-approved medicines in criminal justice settings Ensure access to medications in various crimial justice settings
MMM - Medicare/Medicaid PHA - Pharmacy ALC - Alcohol and Drug Abuse LAW - Law Enforcement/Crime/Criminal Justice
2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA) 2 - HOUSE OF REPRESENTATIVES 37 - Justice, Dept of (DOJ) 1 - SENATE 141 - Substance Abuse & Mental Health Services Administration (SAMHSA)
ALKERMES, INC.
900 Winter Street, Waltham, MA, 02451, US
PETER NORMAN ROBERT FORMAN PETER NORMAN PETER NORMAN ROBERT FORMAN PETER NORMAN ROBERT FORMAN